Roche Laboratories, teamed with other researchers, just published results describing a compound that reverses impaired brain cell signaling in a mouse model with Down syndrome.
Roche Laboratories, teamed with other researchers, just published results describing a compound that reverses impaired brain cell signaling in a mouse model with Down syndrome.